Search

Anodization is a widely used method to obtain multicoloured oxidized titanium sheets. However, most researchers paid great attention to the colour-related properties instead of photoelectrical properties of titanium oxide film obtained by anodization. In this work, to study their photoelectrical properties, a series of multicoloured oxidized titanium sheets were prepared by anodization method, and UV–vis absorption and photocurrents were tested. The relationship between anodization voltages/anodization durations and photocurrents of titanium sheets was studied. Results show that titanium sheets have excellent photoelectrical performance. With the increase of anodization voltage, the number of UV–vis absorption peaks increased under visible light which means increasing absorption. When anodization duration increased, absorption band edge also increased in the visible light region, which means the band gap needed to produce charge transfer transition decreased. Under simulated sunlight and applied voltage of +0.4 V, photocurrent increased with the increase of either anodization voltage or anodization duration, and can be expressed by linear equations. In addition, anodization currents were recorded during anodization. Morphology, crystal structure and photoelectrical properties of anodized titanium sheets were characterized. The anodized titanium sheets can not only be used as decorative material in jewellery and architecture fields etc. but also are supposed to be used as photoelectrical catalyst in further work.

Thymidine kinase 1 in serum (STK1) has been found to be a reliable proliferation marker in clinical trials. In this study, we examined the significance of STK1 in routine clinical settings. The concentration of STK1 was determined by a sensitive dot blot ECL assay. The STK1 value was correlated to clinical stage and reactions and used for monitoring the outcome of surgery and/or multidrug chemotherapy of 1,247 patients with five different types of carcinomas (lung, esophagus, gastric, head and neck, and thyroid) in routine clinical settings. The STK1 values correlated with the clinical stage in patients with lung, esophagus, thyroid, and gastric carcinomas. After treatment, STK1 declined in all tumor groups after treatments ( P < 0.01). The STK1 was low (<2 pM) or decreasing during treatment in patients with clinical reactions of complete response (CR) or partial response (PR), but high (>2 pM) or increasing in patients with stable disease (SD) or progressive disease (PD), some of them showing metastasis. STK1 also reflected the differences in clinical reactions when surgery and chemotherapy were compared. We concluded that the concentration of TK1 in serum correlates to clinical stages and clinical reactions and monitors the effect of tumor therapies, not only in controlled clinical trials, but also in routine clinical settings. [ABSTRACT FROM AUTHOR]